Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention

Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention

Objective: The aim of this study was to investigate the relationship between type of antiresorptive medication and medication-related osteonecrosis of the jaw (MRONJ) onset and the role of premedication dental evaluation (PMDE) in the prevention of MRONJ. Study Design: Our database of patients with...

Full description

Bibliographic Details
Main Authors: Estilo, C.L (Author), Huryn, J.M (Author), Liang, S.T.Y (Author), Owosho, A.A (Author), Sax, A.Z (Author), Wu, K. (Author), Yom, S.K (Author)
Format: Article
Language:English
Published: Mosby Inc. 2018
Subjects:
adult
Adult
aged
Aged
angiogenesis inhibitor
Angiogenesis Inhibitors
bevacizumab
Bevacizumab
Bisphosphonate-Associated Osteonecrosis of the Jaw
bisphosphonic acid derivative
bone density conservation agent
Bone Density Conservation Agents
bone necrosis
chemically induced
denosumab
Denosumab
Diphosphonates
female
Female
human
Humans
imidazole derivative
Imidazoles
incidence
Incidence
indole derivative
Indoles
ipilimumab
Ipilimumab
jaw disease
Jaw Diseases
jaw osteonecrosis
male
Male
middle aged
Middle Aged
neoplasm
Neoplasms
Osteonecrosis
pamidronic acid
pyrrole derivative
Pyrroles
Retrospective Studies
retrospective study
sunitinib
zoledronic acid
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items